{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:38:22Z","timestamp":1777952302329,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.7759\/cureus.108226","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:13:07Z","timestamp":1777896787000},"source":"Crossref","is-referenced-by-count":0,"title":["Latent Tuberculosis Activation Due to Short-Term Glucocorticoid Use in Acute Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Akriti","family":"Jalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Bishr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R","family":"Glover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun H","year":"2015","unstructured":"Getahun H, Matteelli A, Abubakar I, et al.. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015, 46:1563-76. 10.1183\/13993003.01245-2015","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019, 78:1151-9. 10.1136\/annrheumdis-2018-214819","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn DM","year":"2017","unstructured":"Lewinsohn DM, Leonard MK, LoBue PA, et al.. Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017, 64:111-5. 10.1093\/cid\/ciw778","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2020.100181","article-title":"Utility of Mycobacterium tuberculosis PCR in ruling out active disease and impact on isolation requirements in a low prevalence setting","volume":"21","author":"Hamdi A","year":"2020","unstructured":"Hamdi A, Fida M, Deml SM, Abu Saleh O, Wengenack NL. Utility of Mycobacterium tuberculosis PCR in ruling out active disease and impact on isolation requirements in a low prevalence setting. J Clin Tuberc Other Mycobact Dis. 2020, 21:100181. 10.1016\/j.jctube.2020.100181","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2238-y","article-title":"Late-onset systemic lupus erythematosus: clinical features, course, and prognosis","volume":"32","author":"Tomic-Lucic A","year":"2013","unstructured":"Tomic-Lucic A, Petrovic R, Radak-Perovic M, et al.. Late-onset systemic lupus erythematosus: clinical features, course, and prognosis. Clin Rheumatol. 2013, 32:1053-8. 10.1007\/s10067-013-2238-y","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000147737.57861.7c","article-title":"Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature","volume":"83","author":"Boddaert J","year":"2004","unstructured":"Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004, 83:348-59. 10.1097\/01.md.0000147737.57861.7c","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57020084","article-title":"The role of complement system and the immune response to tuberculosis infection","volume":"57","author":"Jagatia H","year":"2021","unstructured":"Jagatia H, Tsolaki AG. The role of complement system and the immune response to tuberculosis infection. Medicina (Kaunas). 2021, 57:84. 10.3390\/medicina57020084","journal-title":"Medicina (Kaunas)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.9.4833","article-title":"Inhibition of IFN-gamma signaling by glucocorticoids","volume":"170","author":"Hu X","year":"2003","unstructured":"Hu X, Li WP, Meng C, Ivashkiv LB. Inhibition of IFN-gamma signaling by glucocorticoids. J Immunol. 2003, 170:4833-9. 10.4049\/jimmunol.170.9.4833","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.10","article-title":"Updates on the risk factors for latent tuberculosis reactivation and their managements","volume":"5","author":"Ai JW","year":"2016","unstructured":"Ai JW, Ruan QL, Liu QH, Zhang WH. Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerg Microbes Infect. 2016, 5:1-8. 10.1038\/emi.2016.10","journal-title":"Emerg Microbes Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick SS","year":"2006","unstructured":"Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006, 55:19-26. 10.1002\/art.21705","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2019-0008","article-title":"Short course of high-dose steroids for anaphylaxis caused flare up of tuberculosis: a case report","volume":"7","author":"Patil S","year":"2019","unstructured":"Patil S, Jadhav A. Short course of high-dose steroids for anaphylaxis caused flare up of tuberculosis: a case report. J Transl Int Med. 2019, 7:39-42. 10.2478\/jtim-2019-0008","journal-title":"J Transl Int Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000001032","article-title":"Reactivation of pulmonary tuberculosis in a patient with COVID-19: case report and review of literature","volume":"29","author":"Pozdnyakov A","year":"2021","unstructured":"Pozdnyakov A, Jin A, Bader M. Reactivation of pulmonary tuberculosis in a patient with COVID-19: case report and review of literature. Infect Dis Clin Pract (Baltim Md). 2021, 29:e468-70. 10.1097\/IPC.0000000000001032","journal-title":"Infect Dis Clin Pract (Baltim Md)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S447245","article-title":"Incidence and risk factors of active tuberculosis among hospitalized patients with latent tuberculosis infection in China: a cohort study","volume":"17","author":"Liu Y","year":"2024","unstructured":"Liu Y, Zhang L, Chen Y, et al.. Incidence and risk factors of active tuberculosis among hospitalized patients with latent tuberculosis infection in China: a cohort study. Infect Drug Resist. 2024, 17:953-60. 10.2147\/IDR.S447245","journal-title":"Infect Drug Resist"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1625748","article-title":"Tuberculosis in patients with systemic lupus erythematosus","volume":"16","author":"Ongarj J","year":"2025","unstructured":"Ongarj J, Intapiboon P, Tanner R, Pinpathomrat N. Tuberculosis in patients with systemic lupus erythematosus. Front Immunol. 2025, 16:1625748. 10.3389\/fimmu.2025.1625748","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/468567-latent-tuberculosis-activation-due-to-short-term-glucocorticoid-use-in-acute-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:13:07Z","timestamp":1777896787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/468567-latent-tuberculosis-activation-due-to-short-term-glucocorticoid-use-in-acute-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.108226","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,4]]}}}